📖
Outcomes of methylprednisolone as an adjunct to endovascular therapy in patients with diabetes and admission hyperglycemia.
Zhang L, Zhang B, Zhang L, Feng K, Li L, Zhu H, Xu X, Ma J, Zhou S, Wang Z, Li J, Yang Q, Chen Y, Chen M, Yang Y, Fan Y, Yuan J, Song J, Li G, Zhou M

Outcomes of methylprednisolone as an adjunct to endovascular therapy in patients with diabetes and admission hyperglycemia.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Front Endocrinol (Lausanne).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Outcomes of methylprednisolone as an adjunct to endovascular therapy in patients with diabetes and admission hyperglycemia.
Author / Organization Zhang L, Zhang B, Zhang L, Feng K, Li L, Zhu H, Xu X, Ma J, Zhou S, Wang Z, Li J, Yang Q, Chen Y, Chen M, Yang Y, Fan Y, Yuan J, Song J, Li G, Zhou M
Subject & Discipline Front Endocrinol (Lausanne)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-59055
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »